146 related articles for article (PubMed ID: 3000159)
1. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
Brezinski ME; Yanagisawa A; Darius H; Lefer AM
Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
[TBL] [Abstract][Full Text] [Related]
2. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
Schrör K; Thiemermann C
Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
Brezinski ME; Yanagisawa A; Lefer AM
J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
[TBL] [Abstract][Full Text] [Related]
5. Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
Hock CE; Brezinski ME; Lefer AM
Eur J Pharmacol; 1986 Mar; 122(2):213-9. PubMed ID: 3011442
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
Bitterman H; Yanagisawa A; Lefer AM
Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Bhat AM; Sacks H; Osborne JA; Lefer AM
Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
[TBL] [Abstract][Full Text] [Related]
8. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
Burke SE; DiCola G; Lefer AM
J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Osborne JA; Lefer AM
Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
[TBL] [Abstract][Full Text] [Related]
10. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
Grover GJ; Schumacher WA
Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
[TBL] [Abstract][Full Text] [Related]
11. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
Burke SE; Roth DM; Lefer AM
Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
Tsao PS; Lefer AM
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
[TBL] [Abstract][Full Text] [Related]
15. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
[TBL] [Abstract][Full Text] [Related]
17. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
[TBL] [Abstract][Full Text] [Related]
18. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
Grover GJ; Schumacher WA; Simon M; Parham C
J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
[TBL] [Abstract][Full Text] [Related]
19. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
[TBL] [Abstract][Full Text] [Related]
20. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
Lefer AM; Burke SE; Lepran I
Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
